KR100543082B1 - A manufacturing process of composition for reducing the body weight and cholesterol - Google Patents
A manufacturing process of composition for reducing the body weight and cholesterol Download PDFInfo
- Publication number
- KR100543082B1 KR100543082B1 KR1020030054936A KR20030054936A KR100543082B1 KR 100543082 B1 KR100543082 B1 KR 100543082B1 KR 1020030054936 A KR1020030054936 A KR 1020030054936A KR 20030054936 A KR20030054936 A KR 20030054936A KR 100543082 B1 KR100543082 B1 KR 100543082B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- sterilization
- hours
- extract
- transferring
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 235000012000 cholesterol Nutrition 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 5
- 230000037396 body weight Effects 0.000 title description 9
- 230000004580 weight loss Effects 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 11
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 10
- 229940010454 licorice Drugs 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 9
- 230000009467 reduction Effects 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 240000000724 Berberis vulgaris Species 0.000 claims abstract description 5
- 235000016068 Berberis vulgaris Nutrition 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 239000004744 fabric Substances 0.000 claims abstract description 4
- 239000011521 glass Substances 0.000 claims abstract description 4
- 239000012535 impurity Substances 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 3
- 238000012856 packing Methods 0.000 claims abstract 3
- 239000004480 active ingredient Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 235000012206 bottled water Nutrition 0.000 claims description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 238000012857 repacking Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 241000202807 Glycyrrhiza Species 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract description 4
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract description 4
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract description 4
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract description 4
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract description 4
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract description 4
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract description 4
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 abstract description 4
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract description 4
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract description 4
- 230000003796 beauty Effects 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- 201000001320 Atherosclerosis Diseases 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 230000000069 prophylactic effect Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 240000006831 Rubus chamaemorus Species 0.000 abstract 1
- 235000016554 Rubus chamaemorus Nutrition 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000010977 jade Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 238000003860 storage Methods 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 description 28
- 235000020824 obesity Nutrition 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 239000003925 fat Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 235000009200 high fat diet Nutrition 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010033307 Overweight Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 108090000992 Transferases Proteins 0.000 description 4
- 102000004357 Transferases Human genes 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 235000011229 Prunus domestica subsp. syriaca Nutrition 0.000 description 3
- 244000169641 Spondias dulcis Species 0.000 description 3
- 235000005138 Spondias dulcis Nutrition 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 244000010000 Hovenia dulcis Species 0.000 description 2
- 235000008584 Hovenia dulcis Nutrition 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 229940009098 aspartate Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241000110634 Sarcocornia perennis Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013542 behavioral therapy Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/16—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by heating loose unpacked materials
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2221/00—Applications of separation devices
- B01D2221/06—Separation devices for industrial food processing or agriculture
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B25/00—Packaging other articles presenting special problems
- B65B25/001—Packaging other articles presenting special problems of foodstuffs, combined with their conservation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 체중감량 및 콜레스테롤 감소용 식품 조성물의 제조방법에 관한 것으로, 보다 상세하게는 헛개나무 45중량중량%, 헛개나무 열매(지구자) 33중량%, 황매목 10중량%, 다엽 7중량%, 감초 3중량%, 옥촉수 2중량%의 중량비로 준비하는 재료 배합비율 설정단계와; 위 재료를 배합비율대로 추출기에 넣고 적당량의 생수물을 붓는 추출준비단계와; 추출기에 100∼120℃로 5∼6시간 가열하여 재료가 함유하고 있는 성분을 추출하는 추출단계와; 추출한 액을 여과기로 옮겨 미세한 여과포로 여과하는 불순물여과단계와; 여과한 추출액을 살균기로 옮겨 100℃로 1차살균하는 1차살균단계와; 살균한 추출액을 자동포장기로 위생 유리병에 100㎖씩 밀폐 포장하는 밀폐포장단계와; 완성된 제품을 적당 수량씩 종이박스에 재 포장하여 2차 살균기로 옮겨 100℃로 2시간 살균하는 2차살균단계 및 직사광선을 피한 실온에 보관하고 출하하는 보관출하단계로 이루어져, 고지방 식이 등에 따른 비만 및 동맥경화의 의 예방 또는 치료보조제로서, 미용 등을 위한 체중감량제 또는 체중감량 보조제로서 매우 유용하게 사용될 수 있는 효과가 있다.The present invention relates to a method for producing a food composition for weight loss and cholesterol reduction, more specifically, 45% by weight of hawthorn tree, fruit of hawthorn (earths) 33% by weight, yellowberry 10% by weight, multileaf 7% by weight A material blending ratio setting step of preparing at a weight ratio of licorice 3% by weight and 2% by weight of tactile water; An extraction preparation step of pouring the appropriate amount of mineral water into the extractor according to the mixing ratio; An extraction step of extracting a component contained in the material by heating the extractor at 100 to 120 ° C. for 5 to 6 hours; An impurity filtration step of transferring the extracted solution to a filter and filtration with a fine filter cloth; A first sterilization step of transferring the filtered extract solution to a sterilizer for first sterilization at 100 ° C .; An airtight packing step of hermetically extracting the sterilized extract liquid in a sanitary glass bottle by an automatic packing machine; The finished product is repacked in a suitable quantity in a paper box and transferred to a secondary sterilizer, followed by a secondary sterilization step for sterilization at 100 ° C. for 2 hours, and a storage shipment step for storing and shipping at room temperature away from direct sunlight. And as a prophylactic or therapeutic aid of atherosclerosis, there is an effect that can be very useful as a weight loss agent or weight loss aid for beauty and the like.
헛개나무, 지구자, 옥촉수, 황매목, 다엽, 감초Barn Trees, Earths, Jade Tentacles, Barberry, Multileaf, Licorice
Description
본 발명은 체중감량 및 콜레스테롤 감소용 식품 조성물의 제조방법에 관한 것으로서, 보다 상세하게는 고지방 식이 등에 따른 비만 및 동맥경화의 의 예방 또는 치료보조제로서, 미용 등을 위한 체중감량제 또는 체중감량 보조제로서 매우 유용하게 사용될 수 있는 체중감량 및 콜레스테롤 감소용 식품 조성물의 제조방법에 관한 것이다.The present invention relates to a method for preparing a food composition for weight loss and cholesterol reduction, and more particularly, as a weight loss agent or weight loss aid for beauty, etc. It relates to a method for preparing a food composition for weight loss and cholesterol reduction that can be very usefully used.
일반적으로, 현대인들이 가지고 있는 질병의 원인은 대부분 사회환경에 육체가 잘 적응하지 못하기 때문에 발생한다. In general, most of the causes of modern diseases are caused by the body's poor adaptation to the social environment.
이런 현대인의 5대 질환인 심장병, 고혈압, 당뇨, 뇌졸증, 암의 발병 원인은 이동수단의 편의성을 추구하는데 따른 운동부족, 서구식 육식위주의 식사에 의한 영양 과잉으로 인한 비만 때문이다.The five major diseases of modern people, heart disease, high blood pressure, diabetes, stroke, and cancer, are caused by lack of exercise in pursuit of convenience of transportation and obesity due to overnourishment caused by western meat-based meals.
비만(肥滿, Obesity)은 과다한 체지방을 가진 상태를 이르는 말로, 남자는 체지방이 체중의 25%, 여자는 체중의 30% 이상일 때, 임상적으로는 BMI(Body mass index:체질량지수)가 30.1 이상인 경우, 현재체중이 이상체중을 20% 초과하는 경우로 정의된다. Obesity refers to a condition with excessive body fat. When the body fat is 25% of the body weight of men and the body weight is more than 30% of the body weight, clinically, the body mass index (BMI) is 30.1. The above case is defined as the case where the present body weight exceeds the ideal body weight by 20%.
비만의 원인으로는 유전적 요인, 환경적 요인, 에너지 대상의 이상 등이 있다. 비만의 종류에는 원인에 따라서, 단순 비만과 증후성 비만으로 분류할 수 있다. 단순 비만은 과식과 운동 부족이 그 원인이며, 증후성 비만은 내분비, 시상하부성, 유전, 전두엽 및 대사성 등으로 발생한다.Obesity can be caused by genetics, environmental factors, and abnormal energy targets. Types of obesity can be classified into simple obesity and symptomatic obesity, depending on the cause. Simple obesity is caused by overeating and lack of exercise, and symptomatic obesity is caused by endocrine, hypothalamic, hereditary, frontal and metabolic.
비만도의 평가에는 체중을 측정하는 방법, 피부주름 두께 측정법(캘리퍼를 사용)이 있다. 비만도 지수를 평가하는 임상적인 방법에는 이상체중법(Modified Broca's method)으로 가장 쉽게 사용하는 방법이며 [신장(cm)-100]X0.9를 이상체중으로 계산하여 현재체중을 백분율화시키는 방법이다. 비만도= (실측체중-표준체중)/표준체중×100%로 계산한다. 체질량지수는 체중을 신장의 제곱으로 나눈 것이다. BMI는 체지방과 관련이 되며 상대적으로 신장에 영향을 받지 않는다. 정상은 BMI=20.1∼25이며 과체중은 BMI가 25∼29.9로 정의된다. 비만은BMI가 30 이상인 것이며, 고도비만은 BMI가 40.1보다 클 때이다.There are two methods for evaluating obesity: measuring body weight and measuring skin wrinkles (using a caliper). The clinical method of evaluating the obesity index is the most easily used by the Modified Broca's method, and it is a method of calculating the [height (cm) -100] X0.9 as the ideal weight to percentage the current weight. Obesity degree = (measured body weight-standard weight) / standard weight × 100%. Body mass index is weight divided by height squared. BMI is associated with body fat and is relatively unaffected by height. Normal is defined as BMI = 20.1-25 and overweight BMI 25-259.9. Obesity is when BMI is over 30 and high obesity is when BMI is greater than 40.1.
kaup지수는 2세 미만의 연령에서 사용하는 방법이며 18 이상이면 비만이다. 체중(g)/신장(cm)x100이다. Rohler지수는 학교에서 학생의 비만판정 지수로 많이 사용하며 체중(kg)/신장(cm)3x107으로 신장이 110∼129cm에서 180 이상이고 130∼149cm에서는 170 이상, 150cm 이상에는 160 이상을 비만으로 판정한다. The kaup index is used for ages under 2 years of age. Body weight (g) / height (cm) × 100. The Rohler index is widely used as a student's obesity judgment index at school, and weight (kg) / height (cm) is 3x107, and height is over 180 at 110-129cm, over 170 at 130-149cm, and over 160 at 150cm. do.
비만으로 인한 질병에는 관상동맥질환, 당뇨병, 고중성지방혈증, 고혈압 등이 있다. 비만의 치료에는 식이요법, 운동요법, 행동수정요법, 약물요법 등이 있다. Obesity-related diseases include coronary artery disease, diabetes, hypertriglyceridemia and hypertension. Treatments of obesity include diet, exercise, behavioral therapy and drug therapy.
또한, 비만증(肥滿症, obesity)은 몸에 지방질이 많아져서 지나치게 뚱뚱해지며 운동장애나 기능장애를 일으키는 증세로, 비만증의 대부분은 섭취한 열량 중에서 소모되고 남은 부분이 지방으로 전환되어 체내의 여러 부분 특히, 피하조직과 복강 내에 축적되는 현상이다. In addition, obesity is a condition in which the body becomes too fat due to excessive fat and causes dyskinesia or dysfunction. Most of obesity is consumed from the calories ingested, and the remaining portion is converted to fat, which leads to various parts of the body. In particular, it is a phenomenon that accumulates in the subcutaneous tissue and the abdominal cavity.
비만증 환자는 지방조직의 기능에 필요한 지방량보다 훨씬 많은 지방이 체내에 축적되어 인체내의 정상적인 생화학적 및 생리적 기능에 장애를 중 뿐만 아니라, 여러 가지 질환, 특히 당뇨병, 고지혈증, 고혈압 및 관상동맥질환의 원인이 되기 때문에 예방과 조기치료에 많은 노력을 기울여야만 한다.Obesity patients accumulate much more fat in the body than the amount of fat needed for the functioning of adipose tissue, impairing normal biochemical and physiological functions in the human body, as well as causing various diseases, especially diabetes, hyperlipidemia, hypertension and coronary artery disease. Because of this, a lot of effort must be put into prevention and early treatment.
비만과 관련된 물질 중 하나인 콜레스테롤은 인체의 기능을 정상적으로 유지하는데 필수적으로 필요한 지방질의 하나이며, 부신피질 호르몬, 남성호르몬, 여성호르몬 등 여러가지 호르몬의 재료가 된다.Cholesterol, one of the substances associated with obesity, is one of the essential fats necessary to maintain the normal function of the human body, and is a material of various hormones such as corticosteroids, male hormones, and female hormones.
하지만, 필수적인 콜레스테롤이라도 혈중에 농도가 높으면 협심증이나 심근경색증(허혈성 심장병)이 증가하는 원인이 된다. 콜레스테롤은 흡수된 다음 혈액과 함께 순환하게 된다.However, high levels of blood cholesterol, even essential cholesterol, can cause angina and myocardial infarction (ischemic heart disease). Cholesterol is absorbed and then circulated with the blood.
이런 비만과 과체중의 사람들에게는 주로 혈당수치가 높게 나타나는데 이것은 비만 및 과체중에서 나타나는 인슐린 민감도가 떨어지기 때문이며, 비만 관련 질환에서는 고혈당으로 인한 당뇨 등이 유발되기 쉽다. In the obese and overweight people, the blood sugar level is mainly high because of the decrease in insulin sensitivity in obesity and overweight, and obesity-related diseases are likely to cause diabetes due to hyperglycemia.
이에 본 발명자들은 안전성 등이 확보된 식품으로 분류되어 안심하고 복용할 수 잇는 재료를 이용하여 부작용 없이 비만을 억제할 수 있는 효과를 발휘하는 조성물을 개발해내기 위하여 지속적인 연구를 수행하였다. Therefore, the present inventors conducted a continuous study to develop a composition exhibiting the effect of suppressing obesity without side effects using a material that is classified as a food such as safety and can be taken with confidence.
그 결과, 특정한 재료를 적절히 배합함으로써 상기 언급한 바와 같은 비만 및 과체중으로 인해 발병되는 문제점들을 해결할 수 있음과 동시에 탁월한 효과를 얻을 수 있음을 확인하고, 본 발명을 완성하기에 이르렀다. As a result, it has been confirmed that by properly blending specific materials, the problems caused by obesity and overweight as mentioned above can be solved and excellent effects can be obtained, and the present invention has been completed.
이런 본 발명은 부작용을 유발하지 않으면서 비만 억제 효과에 탁월한 약효를 나타내는 새로운 체중감량 및 콜레스테롤 감소용 식품 조성물의 제조방법을 제공함에 그 목적이 있다.It is an object of the present invention to provide a method for preparing a food composition for weight loss and cholesterol reduction, which exhibits excellent efficacy in inhibiting obesity without causing side effects.
이와 같은 목적을 달성하기 위하여 본 발명에 따른 체중감량 및 콜레스테롤 감소용 식품 조성물의 제조방법은 헛개나무 45중량%, 헛개나무 열매(지구자) 33중량%, 황매목 10중량%, 다엽 7중량%, 감초 3중량%, 옥촉수 2중량%로 이루어지는 원재료를 준비하는 단계와;In order to achieve the above object, the method for preparing a food composition for weight loss and cholesterol reduction according to the present invention is 45% by weight of hawthorn, fruit of hawthorn (earth) 33% by weight, lumberberry 10% by weight, multileaf 7% by weight Preparing a raw material comprising 3% by weight of licorice and 2% by weight of occacia;
삭제delete
삭제delete
삭제delete
삭제delete
상기 원재료를 배합 비율대로 추출기에 넣고 적당량의 생수를 첨가한 다음, 100∼120℃의 온도로 5∼6시간 가열하여 재료가 함유하고 있는 유효 성분을 추출하는 단계와;Adding the raw materials to the extractor in a blending ratio, adding an appropriate amount of bottled water, and then heating the mixture at a temperature of 100 to 120 ° C. for 5 to 6 hours to extract the active ingredient contained in the material;
삭제delete
추출액을 여과기로 옮겨 미세한 여과포로 불순물을 여과하는 단계와;Transferring the extract to a filter and filtering the impurities with a fine filter cloth;
여과한 추출액을 살균기로 옮겨 100℃의 온도로 1차 살균하는 단계와;Transferring the filtered extract to a sterilizer for first sterilization at a temperature of 100 ° C .;
살균한 추출액을 위생 유리병에 밀폐 포장하는 단계와;Sealing the sterilized extract in a sanitary glass bottle;
포장된 완제품을 적당 수량씩 종이박스에 재포장하여 2차 살균기로 옮겨 100℃로 2시간 동안 2차 살균하는 단계로 이루어지는 것을 특징으로 한다.The packaged finished product is repackaged in a suitable quantity in a paper box and moved to a secondary sterilizer, characterized in that the step of secondary sterilization for 2 hours at 100 ℃.
삭제delete
본 발명은 유효성분으로서 헛개나무, 지구자, 황매옥, 다엽, 감초, 옥촉수의 혼합추출물을 동결 건조한 원재료를 이용한 체중감량 및 콜레스테롤 감소용 식품 조성물의 제조방법을 제공한다. 즉, 헛개나무, 지구자, 황매옥, 다엽, 감초, 옥촉수의 진탕액을 제조한다. 때에 따라서는 다엽와 생강나무(황매목), 감초를 더 첨가시킬 수도 있다.The present invention provides a method for producing a food composition for weight loss and cholesterol reduction using a raw material freeze-dried a mixed extract of the bark tree, earth, yellow leaf, multi-leaf, licorice, octagonal water as an active ingredient. In other words, a shaker of a bark, earth, yellow plum, multileaf, licorice, and tentacles is prepared. Occasionally, multiple leaves, ginger trees, and licorice may be added.
이하, 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.
본 발명은 유효성분으로서 헛개나무, 지구자, 옥촉수, 생강나무(황매목), 다엽, 감초의 혼합추출물을 함유하는 체중감량 및 콜레스테롤 감소용 식품 조성물에 관한 것이다.The present invention relates to a weight loss and cholesterol-lowering food composition containing a mixed extract of the bark tree, earth, locust, ginger tree (yellow plum), multileaf, licorice as an active ingredient.
본 발명에 따른 조성물의 제1 유효성분인 헛개나무(학명: hovenia dulcis thunberg, 과명: Rhamnaceae)는 숙취해소, 간기능 보호작용 등을 가진다.The first active ingredient of the composition according to the present invention (Hoffenia hovenia dulcis thunberg, scientific name: Rhamnaceae) has a hangover relief, liver function protection and the like.
헛개나무는 재배하여 3년 이하의 잎과 가지를 사용한다. 우리나라 울릉도, 강원도 등 중부이남 일부지역에 한하여 극히 드물게 군락을 이루며 자생하는 아주 귀한 나무이다. 또한 활엽수 대부분이 그렇듯이 헛개나무도 오래된 나무는 독특한 이취(구린내)가 배어있어 식품으로 가공할 시 음용하기 역겹고 효능도 어린 나무보다 10배정도 떨어진다. 처서가 지난 이후부터 단풍이 들기 전까지 채취가 가능하며, 채취시 잎과 가지를 혼합하여 절단기에 2∼3cm 정도로 절단하여 덮개로 덮어 약 48시간 숙성(띄움)시켜 음건하여 보관한다.Bare tree is grown and uses leaves and branches less than 3 years old. It is a very rare tree that grows very rarely in a colony only in parts of south central part of Korea such as Ulleungdo and Gangwon-do. In addition, as with most hardwoods, old trees have a unique odor, which is disgusting to drink when processed into food, and 10 times less effective than young trees. After harvesting, it can be harvested until the leaves fall. When harvesting, the leaves and branches are mixed, cut into 2 ~ 3cm with a cutter, covered with a cover, aged for 48 hours, and stored in the shade.
이런 헛개나무는 갈매나무과의 낙엽교목으로, 지구자나무라고도 한다. 높이 10~17 m이고 수피(樹皮)는 흑회색이며 작은가지는 갈자색(褐紫色)으로 피목(皮目)이 있다. 겨울눈은 2개의 눈비늘[芽鱗]로 싸여 있으며털이 있다. 잎은 길이 8~15 cm이며 어긋나고 넓은 난형 또는 타원형이다. 잎에 3개의 굵은 잎맥이 발달하고 가장자리에 잔톱니가 있다. 자웅이주로 6~7월에 흰색 꽃이 피는데 양성화(兩性花)이다. 꽃은 취산꽃차례로 달린다. 꽃받침조각과 꽃잎은 5개씩이고 암술대는 3개로 갈 라진다. 열매는 갈색이 돌고 지름 8 mm 정도이며 닭의 발톱 모양이다. 열매의 3실에 각각 1개씩의 종자가 들어 있다. 종자는 다갈색이고 윤기가 있다. This barn tree is a deciduous tree of the sea buckthorn family, also called the earth tree. Its height is 10 ~ 17 m and the bark is black gray and the twig is brown purple. Winter snow is covered with two snow scales and has hairs. Leaves are 8-15 cm long, alternate, broad ovate or oval. Three coarse leaf veins develop on the leaves and fine teeth on the edges. It is a bisexual flower that blooms white flowers in June ~ July. The flowers run in an inflorescence. Sepals and petals are 5 pieces each, and pistil is divided into 3 pieces. Fruits are brown, about 8 mm in diameter, and look like chicken claws. Three seeds of fruit contain one seed each. Seeds are dark brown and glossy.
열매인 지구자가 익을 무렵이면 과경(果莖)이 굵어져서 울퉁불퉁하게 된다. 은은한 향기가 있고, 단맛이 있어 먹을 수 있으며 음식맛을 한결 돋운다. 《본초강목》에 술을 썩히는 작용이 있다고 하며 생즙은 술독을 풀고 구역질을 멎게 한다고 하였다. 목재는 건축재, 가구재, 악기재 등으로 사용한다. 한국(강원과 황해 이남), 일본, 중국에 분포한다When fruit, the earth's ripening fruit, becomes thicker and thicker. It has a subtle scent, sweetness, and can be eaten. The herbal wood is said to have a decaying effect on alcohol, and the juice is said to detoxify the alcohol and stop nausea. Wood is used for building materials, furniture materials and musical instruments. Distributed in Korea (Gangwon and South Yellow Sea), Japan and China
본 발명에 따른 조성물의 제2 유효성분인 지구자((hovenia dulcis thunberg)는 혈중알콜농도 저하능력이 뛰어나 주독해소제로 사용되고있으며, 간독성, 지방간, 간염치료에 효과를 지니고 있다.The second active ingredient (hovenia dulcis thunberg) of the composition according to the present invention has excellent blood alcohol concentration lowering ability and is used as a main toxic antiseptic and has an effect on the treatment of liver toxicity, fatty liver, and hepatitis.
지구자는 헛개나무의 열매로, 생태적으로 8년 이상 자라야 열매(지구자)가 맺기 시작하므로 헛개나무의 신비한 효능이 밝혀지기 시작한지 약 5년, 국내 몇몇 관심있는 이들이 재배를 시작한지 약 8년 정도 이어서 국내산 지구자는 자연생 채취에 의존하나 소량이므로 수급이 매우 어려운 실정이다. 중국산이 다량 수입되지만 효능, 효과가 국내산에 비해 10분지 1도 못 미친다. 지구자는 효능, 효과가 비슷한 북한산을 사용한다. 이런, 지구자는 헛개나무의 열매를 약용한 것으로 맛은 달고 성질은 평하다. 체한 사람, 창에 다쳐 생긴 염증, 치질 등에 효능이 있다.The earth is the fruit of the bark tree, which grows more than 8 years ecologically, and since the fruit (earth) begins to bear, the mysterious efficacy of the bark tree begins to be revealed about 5 years, and about 8 years after some interested people have started growing. Subsequently, domestic earth globes rely on natural harvesting, but supply and demand is very difficult because they are small. Although a large amount of Chinese products are imported, its efficacy and effect is less than one tenth of that of domestic products. The earth uses Bukhansan, which has similar efficacy and effect. The earth is medicinal in the fruit of the barn tree, and the taste is sweet and the nature is flat. It is effective for people who are injured, wounds caused by injuries, and hemorrhoids.
본 발명에 따른 조성물의 제3 유효성분인 옥촉수(maydis stigma)는 이뇨작용이 강하고 혈관을 확장해 혈압을 내리며, 혈당강화, 단증분비촉진, 지혈작용 등에 효과를 지닌다. 옥촉수는 옥수수 수염을 말하며 국내 토종 옥촉수(옥수수의 수염) 를 채취하여 음건한 것을 엄선 구입한다.The third active ingredient, maydis stigma, of the composition according to the present invention has a diuretic effect and dilates blood vessels to lower blood pressure, and has an effect on blood sugar strengthening, accelerated secretion, and hemostatic action. Ok Tak Chok means corn whiskers, and selects domestically-grown ox tentacle (corn whiskers) and carefully selects dry ones.
본 발명에 따른 조성물의 제4 유효성분인 황매목은 (생강나무라고도 일컬음) 한방에서는 나무껍질을 삼첩풍이라는 약재료도 쓰이는데, 타박상의 어혈과 산후에 몸이 붓고 팔다리가 아픈 증세에 효과가 있으며, 우리나라 전 지역에 많이 분포되어 자생하므로 아주 흔하다. 낙엽이 진 후부터 잎이 피기 전(황매목은 잎보다 꽃이 먼저 핌)까지 채취하여 잘게 절단하여 음건하여 보관한다. The fourth active ingredient of the composition according to the present invention, Hwangmaemok (also known as ginger tree) is also used in the herbal medicine called the bark of sampyeop, which is effective for the symptoms of swelling of the bruises and swelling and limbs in the postpartum, It is very common because it is distributed in many parts of Korea. After deciduous leaves and before the leaves bloom (Yellow plum flowers bloom before the leaves), cut them finely and store them in the shade.
본 발명에 따른 조성물의 제5 유효성분인 다엽은 열을 내리고 해독작용, 청심이뇨작용 등의 효능을 지니며, 전남 보성 등 재배단지에서 질 좋은 것을 채취하여 음건한 녹차를 엄선하여 구입한다.The fifth active ingredient of the composition according to the present invention, the multileaf has the effect of lowering heat, detoxification, cheongsimdiuresis, etc., and collects quality tea from botanical gardens such as Boseong, Jeonnam, and carefully selects and purchases green tea.
감초는 국내에서도 재배가 시작되어 수급이 가능하나 중국산 영감초에 미치지 못하므로 중국산 영감초를 엄선 구입하여 사용한다. Licorice is cultivated in Korea and can be supplied. However, it is less than Chinese inspired vinegar.
이러한 상기 재료들을 사용한 본 발명 체중감량 및 콜레스테롤 감소용 식품 조성물의 제조방법은 다음과 같다.Method for producing a food composition for weight loss and cholesterol reduction using the above materials is as follows.
실시예 1Example 1
1. 원재료 준비 단계1. Raw Material Preparation Step
헛개나무 45중량%, 헛개나무 열매(지구자) 33중량%, 황매목 10중량%, 다엽 7중량%, 감초 3중량%, 옥촉수 2중량%로 이루어지는 원재료를 준비한다. Prepare raw materials consisting of 45% by weight of bark tree, 33% by weight of fruit of bark tree (earth), 10% by weight of yellow barberry, 7% by weight of multileaf, licorice 3% by weight, and 2% by weight of locust.
2. 추출 단계2. Extraction Step
위 원재료를 배합 비율대로 추출기에 넣고 적당량의 생수를 첨가한 다음,추출기를 100∼120℃로 5∼6시간 가열하여 원재료가 함유하고 있는 유효성분을 추출한다. Put the above raw materials into the extractor in the blending ratio, add an appropriate amount of bottled water, and then heat the extractor at 100-120 ° C for 5-6 hours to extract the active ingredients contained in the raw materials.
삭제delete
삭제delete
3. 불순물 여과단계3. Impurity filtration step
추출액을 여과기로 옮겨 미세한 여과포로 여과한다. The extract is transferred to a filter and filtered through a fine filter cloth.
4. 1차 살균단계4. First sterilization step
여과한 추출액을 살균기로 옮겨 100℃로 1차 살균한다. The filtered extract is transferred to a sterilizer and firstly sterilized at 100 ° C.
5. 밀폐 포장단계5. Hermetic packaging
살균한 추출액을 자동포장기로 위생 유리병에 에컨대 100㎖씩 밀폐 포장한다. The sterilized extract is sealed in 100ml of hygienic glass bottles with an automatic packaging machine.
6. 2차 살균단계6. Secondary Sterilization Stage
완성된 완제품을 적당 수량씩 종이박스에 재 포장하여 2차 살균기로 옮겨 100℃로 2시간 살균한다. The finished product is repacked in appropriate quantity in a paper box and transferred to a secondary sterilizer for 2 hours at 100 ° C.
삭제delete
이러한 단계를 거쳐서 제조되는 본 발명의 식품 조성물은 추출음료로서, 성상은 갈색으로 음료 고유의 색깔과 향미를 지니며, 유통기간은 2년이다.The food composition of the present invention prepared through such a step is an extract beverage, the appearance is brown and has a unique color and flavor of the beverage, the shelf life is two years.
실시예 2Example 2
헛개나무 70중량%(30∼70중량%), 지구자 25중량%(10∼50중량%), 저령 2.5중량%(10∼50중량%), 옥촉수 2.5중량%를 비율대로 혼합하고 정제수를 전탕하여 추출액을 제조하고, 기타 공정은 실시예 1과 동일하게 실시하였다. Mix 70% by weight (30-70% by weight), 25% by weight (10-50% by weight), 2.5% by weight (10-50% by weight), 2.5% by weight of tactile water, and purified water. The extract was prepared by pouring, and the other steps were carried out in the same manner as in Example 1.
실험예 1(체중 감량 효과)Experimental Example 1 (weight loss effect)
실험동물은 C57/BL6 종의 수컷(15.2∼17.4g) 흰쥐를 10마리씩 4군으로 분류하여 다음과 같이 실험하였다.Experimental animals were divided into four groups of 10 males (15.2∼17.4g) rats of C57 / BL6 species and tested as follows.
정상군에게는 일반 사료를 제공하였고, 대조군에게는 고지방 식이군으로 전체 열량의 15중량%를 지방 열량으로 조성하였다.The normal group was provided with normal feed, and the control group was composed of 15% by weight fat calories as a high fat diet group.
상기 고지방 식이군 중에서 2군의 실험군을 분리하여 각각 본 발명의 실시예 1에 따라 제조된 조성물을 고형분으로 환산하여 10중량%와 20중량%를 첨가한 사료를 제공하였다(이하, 10중량% 실험군, 20중량% 실험군으로 표기함.) 물과 사료는 자유롭게 먹을 수 있도록 하였다.Separation of the experimental group of the two groups from the high-fat diet group, respectively, to provide a feed added 10% by weight and 20% by weight of the composition prepared according to Example 1 of the present invention (hereinafter, 10% by weight experimental group) , 20% by weight as experimental group.) Water and feed were allowed to eat freely.
8주 동안 일주일에 한번씩 체중 변화를 측정하였다.Weight change was measured once a week for 8 weeks.
실험한 결과, < 그림 1 > 에서 볼 수 있듯이, 8주 후, 고지방 식이군은 평균 7.1g의 체중이 증가하였으며, 10중량% 실험군 및 20중량% 실험군은 각각 5.1g, 4.9g의 체중이 증가하여 고지방 식이군에 비해 각각 28.2중량%, 31중량%의 체중 증가량을 억제하였다(P = 0.05).As shown in <Figure 1>, after 8 weeks, the high fat diet group gained an average weight of 7.1g, and the 10% and 20% weight groups increased 5.1g and 4.9g, respectively. As a result, 28.2% by weight and 31% by weight of the weight gain were inhibited compared to the high fat diet group (P = 0.05).
다음 < 그림 1 > 은 실험군에 의한 흰쥐의 체중 변화를 나타낸 것이다.<Figure 1> shows the weight change of rats by experimental group.
삭제delete
실험예 2(혈청 중 콜레스테롤 및 혈당 함량 분석)Experimental Example 2 (Analysis of Cholesterol and Glucose Content in Serum)
8주간의 식이 실험 이후, 12시간 동안 절식시키고 에틸에테르로 마취시킨 후, 개복하여 심실에서 1회용 주사기를 이용하여 혈액을 체취하였으며, 3,000rpm으로 20분간 원심 분리하여 얻은 혈청을 시료로 사용하였다.After 8 weeks of dietary experiment, fasted for 12 hours, anesthetized with ethyl ether, and then opened, the blood was collected using a disposable syringe in the ventricles, and serum obtained by centrifugation at 3,000 rpm for 20 minutes was used as a sample.
혈청의 지질성분인 총 콜레스테롤(total cholesterol)의 함량과 글루코스(glucose), 알라닌 전이효소(ALT; Alanine Transaminase), 아스파테이트 전이효소(AST; Aspartate Transaminase)의 함량을 각각 측정하였다.Total cholesterol, total lipid, glucose, alanine transaminase (ALT) and aspartate transaminase (AST) were measured.
다음 < 그림 2 > 는 실험군에 대한 혈청 중 콜레스테롤의 변화를 나타낸 것이다.<Figure 2> shows the change of serum cholesterol in the experimental group.
삭제delete
실험 결과, 상기 < 그림 2 > 에 나타낸 바와 같이, 대조군의 총 콜레스테롤 함량은 179.6mg/dl 로 정상 식이군에 비해 증가하였으나, 10중량% 실험군, 20중량% 실험군은 각각 124mg/dl, 131mg/dl 로 대조군에 비해 각각 31중량%, 27중량% 감소하는 결과를 보였다.As a result, as shown in the <Figure 2>, the total cholesterol content of the control group was increased to 179.6 mg / dl compared to the normal diet group, but the 10 wt% test group and the 20 wt% test group were 124 mg / dl and 131 mg / dl, respectively. As compared with the control group, the results were reduced by 31% by weight and 27% by weight, respectively.
그러나, 알라닌 전이효소(ALT), 아스파테이트 전이효소(AST)의 변화는 거의 없었다.However, there was little change in alanine transferase (ALT) and aspartate transferase (AST).
다음 < 그림 3 >은 실험군에 의한 혈청 중 글루코스의 변화를 나타낸 것이다.<Figure 3> shows the change of glucose in serum by experimental group.
삭제delete
실험 결과, 상기 < 그림 3 > 에 나타낸 바와 같이, 대조군의 혈당은 정상식이군에 비해 156mg/dl로 증가하였으나, 10중량% 실험군, 20중량% 실험군은 각각 116mg/dl, 140mg/dl로 대조군에 비해 각각 25.8중량%, 10.3중량% 감소하였다.As a result, as shown in <Figure 3>, the blood sugar of the control group was increased to 156 mg / dl compared to the normal diet group, but the 10 wt% test group and the 20 wt% test group were 116 mg / dl and 140 mg / dl, respectively, compared to the control group. 25.8% by weight and 10.3% by weight, respectively.
상기 실험 결과는 본 발명의 조성물이 혈중 콜레스테롤 대사를 조절하는 효능이 있다는 것을 보여 주며, 따라서 본 발명의 조성물이 고지혈증에 의한 동맥경화나 심혈관 질환 등에 쓰일 수 있다는 것을 입증한다.The experimental results show that the composition of the present invention is effective in regulating blood cholesterol metabolism, and thus, the composition of the present invention can be used for arteriosclerosis or cardiovascular disease caused by hyperlipidemia.
또한, 대조군에 비해 혈당이 낮다는 것은 본 발명의 조성물이 비만 및 과체중에서 나타나는 인슐린의 내담성을 완화시켜 비만으로 인한 당뇨병 질환에 쓰일 수 있다는 것을 의미한다.In addition, the low blood sugar compared to the control means that the composition of the present invention can be used in diabetic diseases due to obesity by relieving the tolerability of insulin appearing in obesity and overweight.
그리고, 본 발명의 조성물이 간기능의 지표인 알라닌 전이효소(ALT) 및 아스파테이트 전이효소(AST)에는 영향을 미치지 않았으므로 간에 영향을 미치지 않는다는 것을 확인하였다.In addition, since the composition of the present invention did not affect the alanine transferase (ALT) and aspartate transferase (AST) which is an indicator of liver function, it was confirmed that it does not affect the liver.
이상의 실험 결과에서 알 수 있듯이 본 발명의 조성물은 고지방 식이에 의한 체중 및 총 콜레스테롤치를 억제시키는 제품으로 유용하게 사용될 수 있다.As can be seen from the above experimental results, the composition of the present invention can be usefully used as a product for suppressing body weight and total cholesterol by high fat diet.
고지방 식이에 의한 체중증가를 억제하는 효과는 본 발명의 섬유소에 의한 배변의 촉진에 의해서 체내의 지방축적 및 동맥경화의 원인인 총 콜레스테롤량을 낯추는 것으로부터 기인한다고 생각되어진다.The effect of suppressing weight gain due to a high fat diet is thought to result from the reduction of the total amount of cholesterol which causes fat accumulation and arteriosclerosis in the body by promoting bowel movement by the fibrin of the present invention.
따라서 본 발명의 조성물은 고지방 식이 등에 따른 비만 및 동맥경화의 의 예방 또는 치료보조제로서, 미용 등을 위한 체중감량제 또는 체중감량 보조제로서 매우 유용하게 사용될 수 있는 효과가 있다.Therefore, the composition of the present invention has an effect that can be very useful as a weight loss agent or weight loss aid for beauty and the like as a prophylactic or therapeutic aid of obesity and atherosclerosis according to a high fat diet.
본 발명은 상술한 특정의 바람직한 실시예에 한정되지 아니하며, 청구범위에서 청구하는 본 발명의 요지를 벗어남이 없이 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 누구든지 다양한 변형 실시가 가능한 것은 물론이고, 그와 같은 변경은 청구범위 기재의 범위 내에 있게 된다.The present invention is not limited to the above-described specific preferred embodiments, and various modifications can be made by any person having ordinary skill in the art without departing from the gist of the present invention claimed in the claims. Of course, such changes will fall within the scope of the claims.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030054936A KR100543082B1 (en) | 2003-08-08 | 2003-08-08 | A manufacturing process of composition for reducing the body weight and cholesterol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030054936A KR100543082B1 (en) | 2003-08-08 | 2003-08-08 | A manufacturing process of composition for reducing the body weight and cholesterol |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050018701A KR20050018701A (en) | 2005-02-24 |
KR100543082B1 true KR100543082B1 (en) | 2006-01-20 |
Family
ID=37228116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030054936A KR100543082B1 (en) | 2003-08-08 | 2003-08-08 | A manufacturing process of composition for reducing the body weight and cholesterol |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100543082B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7846484B2 (en) | 2004-01-31 | 2010-12-07 | Kiyoung Kim | Composition comprising Hovenia dulcis thunb. extract, Lindera obtusiloba blume extract, or herbal mixture extract thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101314749B1 (en) * | 2011-07-26 | 2013-10-08 | 전승성 | Manufacturing method of composition for tea-bag containing hovenia dulcis and hovenia dulcis fruit |
KR101754528B1 (en) * | 2016-03-23 | 2017-07-06 | 한국광기술원 | Transfer assembly with dry adhesion structure and method for transferring led structure assembly using the same and led structure assembly |
CN106913619B (en) * | 2017-03-14 | 2020-08-11 | 浙江中医药大学 | Extract for promoting reverse cholesterol transport and preparation method and application thereof |
KR102232330B1 (en) * | 2018-02-21 | 2021-03-26 | 경북대학교 산학협력단 | Composition for preventing, treating or improving obesity or obesity-related disease comprising extracts of Lindera obtusiloba Blume leaf |
-
2003
- 2003-08-08 KR KR1020030054936A patent/KR100543082B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7846484B2 (en) | 2004-01-31 | 2010-12-07 | Kiyoung Kim | Composition comprising Hovenia dulcis thunb. extract, Lindera obtusiloba blume extract, or herbal mixture extract thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20050018701A (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100372561B1 (en) | Compositions effective for removing hangover which contains natural herb tea extracts and health supplementing foods containing the same as an effective ingredient | |
KR100543082B1 (en) | A manufacturing process of composition for reducing the body weight and cholesterol | |
AU654365B2 (en) | Stevia extract-containing liquid internal medicine and method of preparing the same | |
CN113631175A (en) | Anti-obesity agent containing allose alcohol as effective component and obesity inhibiting method | |
KR100503208B1 (en) | Diet-food composition | |
CN102125129B (en) | Health care tea | |
KR20090007512A (en) | Emotional tea with spicy, sweety collagen blueberry vita green tea | |
KR20100094223A (en) | The drinking water composition for dissolution of hangover | |
KR102016158B1 (en) | Manufacturing method of feed additive made by byproduct of herbal medicine | |
KR20120009946A (en) | Manufacturing method of drink using onion | |
KR100927435B1 (en) | Pill type a healthy food for improving and alleviating the diabetes and preparation method thereof | |
KR101327802B1 (en) | Fermented extract of eel and manufacturing process of the same | |
KR20090022208A (en) | Sweet flavorous the collagen garlic tea and water | |
KR20060066706A (en) | Emotional tea with spicy, sweety collagen vita orange tea | |
KR20050049134A (en) | Functional food containing pumpkin and its processing method | |
KR102671658B1 (en) | Dietary fiber composition for promoting defecation and improving cholesterol containing psyllium hull and manufacturing method thereof | |
Tkacheva et al. | Clover (lat. Trifolium) | |
KR20090007656A (en) | Emotional lemon tea | |
KR101855820B1 (en) | Composition for improving hepatic function and enhancing stamina | |
KR20060069404A (en) | Emotional tea with spicy, sweety collagen vita apple tea | |
TWM546967U (en) | Red wine structure with health care function | |
Yampolsky et al. | Melon (lat. Cucumis melo) | |
KR20170121033A (en) | Cosmetic composition for lips containing herbal ingredients necessary for women by age group | |
KR100899890B1 (en) | Method for preparing leached tea and extracted tea containing lemon and lemon verbena, and leached tea and extracted tea prepared therefrom | |
KR20060063855A (en) | Emotional tea with spicy, sweety collagen peach vita green tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20111212 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |